Survival in high-grade osteosarcoma: Improvement over 21 years at a single institution

Annals of Oncology

Volumn 21, Issue 6, 2009, Pages 1366-1373

  Picci, P ^a   Mercuri, M ^a   Ferrari, S ^a   Alberghini, M ^a   Briccoli, A ^a   Ferrari, C ^a   Pignotti, E ^a   Bacci, G ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Bone neoplasms; Osteosarcoma; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FOLLOW UP; HEALTH CARE FACILITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; ORTHOPEDIC SURGERY; OSTEOSARCOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT REFUSAL; TUMOR LOCALIZATION; ADOLESCENT; AGED; BIOLOGICAL MODEL; BONE TUMOR; CHILD; EVALUATION STUDY; FEMALE; INFANT; MALE; MIDDLE AGED; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 77954014536     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp502     Document Type: Article

References (18)

1. Jaffe N, Frei E III, Traggis D et al. Adjuvant methotrexate and citrovorumfactor treatment of osteogenic sarcoma. N Engl J Med 1974; 291: 994-997.
2. Cortes EP, Holland JF, Wang JJ et al. Amputation and adriamycin in primary osteosarcoma. N Engl J Med 1974; 291: 998-1000.
3. Campanacci M, Bacci G, Bertoni F et al. The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli. Cancer 1981; 48: 1569-1581.
4. Purfürst C, Beron G, Torggler S et al. Results of the COSS-77 and COSS-80 studies on adjuvant chemotherapy in osteosarcoma of the extremities. Klin Padiatr 1985; 197: 233-238.
5. Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopedics 1985; 8: 659-664.
6. Winkler K, Beron G, Delling G et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329-337.
7. Benjamin RS. Regional chemotherapy for osteosarcoma. Semin Oncol 1989; 16: 323-327.
8. Provisor AJ, Ettinger LJ, Nachman JB et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997; 15: 76-84.
9. Hudson M, Jaffe MR, Jaffe N et al. Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 1990; 8: 1988-1997.
10. Bacci G, Picci P, Ruggieri P et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990; 65: 2539-2553.
11. Bacci G, Picci P, Ferrari S et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 1993; 72: 3227-3238.
12. Fuchs N, Bielack SS, Epler D et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9: 893-899.
13. Souhami RL, Craft AW, Van der Eijken JW et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350: 911-917.
14. Ferrari S, Smeland S, Mercuri M et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23: 8845-8852.
15. Whelan J, Seddon B, Perisoglou M. Management of osteosarcoma. Curr Treat Options Oncol 2006; 7: 444-455.
16. Bacci G, Longhi A, Fagioli F et al. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 2005; 41: 2836-2845.
17. Kim HJ, Fay MP, Feuer EJ et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
18. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004. Data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115: 1531-1543.